Should I buy or sell Simulations Plus stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Simulations Plus in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" SLP shares. View SLP analyst ratings or view top-rated stocks .

What is Simulations Plus' stock price target for 2024?

2 analysts have issued 12-month price objectives for Simulations Plus' stock. Their SLP share price targets range from $51.00 to $55.00. On average, they expect the company's stock price to reach $53.00 in the next year. This suggests a possible upside of 19.3% from the stock's current price. View analysts price targets for SLP or view top-rated stocks among Wall Street analysts .

How have SLP shares performed in 2024?

Simulations Plus' stock was trading at $44.75 at the beginning of the year. Since then, SLP stock has decreased by 0.8% and is now trading at $44.41. View the best growth stocks for 2024 here .

When is Simulations Plus' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 4th 2024. View our SLP earnings forecast .

How were Simulations Plus' earnings last quarter?

Simulations Plus, Inc. (NASDAQ:SLP) released its earnings results on Wednesday, April, 3rd. The technology company reported $0.20 EPS for the quarter, topping the consensus estimate of $0.18 by $0.02. The technology company had revenue of $18.31 million for the quarter, compared to analyst estimates of $17.31 million. Simulations Plus had a trailing twelve-month return on equity of 7.95% and a net margin of 16.22%. Simulations Plus's revenue for the quarter was up 16.2% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.20 earnings per share.

How often does Simulations Plus pay dividends? What is the dividend yield for Simulations Plus?

Simulations Plus declared a quarterly dividend on Wednesday, April 3rd. Shareholders of record on Monday, April 29th will be given a dividend of $0.06 per share on Monday, May 6th. This represents a $0.24 dividend on an annualized basis and a dividend yield of 0.54%. The ex-dividend date of this dividend is Friday, April 26th. Read our dividend analysis for SLP .

Is Simulations Plus a good dividend stock?

Simulations Plus (NASDAQ:SLP) pays an annual dividend of $0.24 per share and currently has a dividend yield of 0.54%. The dividend payout ratio is 45.28%. This payout ratio is at a healthy, sustainable level, below 75%. Read our dividend analysis for SLP .

What ETFs hold Simulations Plus' stock?

ETFs with the largest weight of Simulations Plus (NASDAQ:SLP) stock in their portfolio include AdvisorShares Insiders Advantage ETF (SURE) and Franklin Genomic Advancements ETF (HELX) . Syntax Stratified SmallCap ETF (SSLY) .

What guidance has Simulations Plus issued on next quarter's earnings?

Simulations Plus updated its FY 2024 earnings guidance on Wednesday, April, 3rd. The company provided earnings per share guidance of 0.660-0.680 for the period, compared to the consensus earnings per share estimate of 0.660. The company issued revenue guidance of $66.0 million-$69.0 million, compared to the consensus revenue estimate of $67.2 million.

What other stocks do shareholders of Simulations Plus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Simulations Plus investors own include Advanced Micro Devices (AMD) , Cisco Systems (CSCO) , Gilead Sciences (GILD) , QUALCOMM (QCOM) , NVIDIA (NVDA) , Verizon Communications (VZ) , CVS Health (CVS) , Enterprise Products Partners (EPD) , AbbVie (ABBV) and Pfizer (PFE) .

Who are Simulations Plus' major shareholders?

Simulations Plus' stock is owned by a variety of retail and institutional investors. Top institutional investors include Wasatch Advisors LP (1.91%), Tributary Capital Management LLC (1.05%), Congress Asset Management Co. MA (0.86%), Hennion & Walsh Asset Management Inc. (0.18%), Chatham Capital Group Inc. (0.17%) and InTrack Investment Management Inc (0.16%). Insiders that own company stock include John Anthony Dibella II, John Kenneth Paglia , Lisa Lavange, Walter S Woltosz and Walter S Woltosz . View institutional ownership trends .

How do I buy shares of Simulations Plus?

Shares of SLP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:SLP

Simulations Plus (SLP) Stock Price, News & Analysis

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)

Free SLP Stock Alerts

$44.95

+0.54 (+1.22%)

(As of 10:02 AM ET)

Compare

Today's Range: $44.26
▼
$44.95
50-Day Range: $38.46
▼
$50.73
52-Week Range: $32.69
▼
$52.69

Volume: 4,343 shs
Average Volume: 109,011 shs
Market Capitalization: $898.55 million

P/E Ratio: 84.81
Dividend Yield: 0.53%
Price Target: $53.00

Get Simulations Plus alerts:

Simulations Plus MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 19.3% Upside
$53.00 Price Target
Short Interest: Bearish
7.40% of Float Sold Short
Dividend Strength: Weak
Based on Four Factors
Sustainability: N/A
News Sentiment: 0.45
Based on 4 Articles This Week
Insider Trading: Selling Shares
$1.52 M Sold Last Quarter
Proj. Earnings Growth: N/A

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.77 out of 5 stars

Computer And Technology Sector

450th out of 581 stocks

Computer Integrated Systems Design Industry

20th out of 34 stocks

2.5

Analyst's Opinion

Consensus Rating
Simulations Plus has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Amount of Analyst Coverage
Simulations Plus has received no research coverage in the past 90 days.

0.0

Short Interest

Percentage of Shares Shorted
7.40% of the float of Simulations Plus has been sold short.
Short Interest Ratio / Days to Cover
Simulations Plus has a short interest ratio ("days to cover") of 11.4, which indicates bearish sentiment.
Change versus previous month
Short interest in Simulations Plus has recently increased by 12.15%, indicating that investor sentiment is decreasing significantly.

0.8

Dividend Strength

Dividend Yield
Simulations Plus has a dividend yield of 0.54%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
Simulations Plus does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Simulations Plus is 45.28%. This payout ratio is at a healthy, sustainable level, below 75%.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for SLP.

2.5

News and Social Media Coverage

News Sentiment
Simulations Plus has a news sentiment score of 0.45. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Computer and Technology companies.
News Coverage This Week
MarketBeat has tracked 4 news articles for Simulations Plus this week, compared to 3 articles on an average week.
Search Interest
5 people have searched for SLP on MarketBeat in the last 30 days.

4.2

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Simulations Plus insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,519,089.00 in company stock.
Percentage Held by Insiders
20.90% of the stock of Simulations Plus is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
78.08% of the stock of Simulations Plus is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.3

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Simulations Plus is 83.79, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 134.26.
Price to Earnings Ratio vs. Sector
The P/E ratio of Simulations Plus is 83.79, which means that it is trading at a less expensive P/E ratio than the Computer and Technology sector average P/E ratio of about 219.07.
Price to Book Value per Share Ratio
Simulations Plus has a P/B Ratio of 5.01. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Crypto Swap Profits

Claim Your Complimentary Bitcoin Reward

Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.

Secure Your Spot Now

About Simulations Plus Stock (NASDAQ:SLP)

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. The company also provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, RENAsym, IPFsym, and MITOsym products. In addition, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Further, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Additionally, it offers creative and insightful consulting services to support its quantitative systems pharmacology/quantitative systems toxicology modelling. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.

SLP Stock Price History

30 days | 90 days | 365 days | Advanced Chart

SLP Stock News Headlines

April 3, 2024 | insidertrades.com

Walter S. Woltosz Sells 20,000 Shares of Simulations Plus, Inc. (NASDAQ:SLP) Stock

April 17, 2024 | wsj.com

Simulations Plus Inc.

April 19, 2024 | Weiss Ratings (Ad)

The only accurate crypto trading system I know …

Juan Villaverde is no ordinary crypto trader. His proprietary timing algorithm has led him to rack up a series of gains of 477%, 333% and 153% on Bitcoin … It pointed the way to Cardano, at just 4 cents …Helping investors make 29 times their money.

April 16, 2024 | msn.com

Simulations Plus (NASDAQ:SLP): Promising Potential in Biotech Software

April 15, 2024 | finance.yahoo.com

SLP Sep 2024 55.000 call

April 12, 2024 | investorplace.com

New AI Bot Predicts These 7 Stocks Will Mint Millionaires

April 6, 2024 | seekingalpha.com

Simulations Plus, Inc. (SLP) Q2 2024 Earnings Call Transcript

April 6, 2024 | finance.yahoo.com

Earnings Update: Simulations Plus, Inc. Beat Earnings And Now Analysts Have New Forecasts For This Year

April 19, 2024 | Weiss Ratings (Ad)

The only accurate crypto trading system I know …

April 5, 2024 | finance.yahoo.com

Simulations Plus Second Quarter 2024 Earnings: Beats Expectations

April 4, 2024 | marketwatch.com

Simulations Plus Shares Rise 27% Following FDA's License Renewal for Dilisym Software Platform

April 4, 2024 | msn.com

Simulations Plus stock jumps 25% amid FDA renewal, earnings report

April 4, 2024 | finance.yahoo.com

Simulations Plus, Inc. (NASDAQ:SLP) Q2 2024 Earnings Call Transcript

April 4, 2024 | businesswire.com

U.S. FDA Renews DILIsym® Software Licenses for 7th Year

April 4, 2024 | finance.yahoo.com

Q2 2024 Simulations Plus Inc Earnings Call

April 3, 2024 | seekingalpha.com

Simulations Plus, Inc. 2024 Q2 - Results - Earnings Call Presentation

April 3, 2024 | investorplace.com

SLP Stock Earnings: Simulations Plus Beats EPS, Beats Revenue for Q2 2024

April 3, 2024 | washingtonpost.com

Simulations Plus: Fiscal Q2 Earnings Snapshot

April 3, 2024 | finance.yahoo.com

Simulations Plus Inc (SLP) Aligns with EPS Projections and Maintains Full-Year Guidance

April 3, 2024 | businesswire.com

Simulations Plus Reports Second Quarter Fiscal 2024 Financial Results

April 2, 2024 | msn.com

Simulations Plus Q2 2024 Earnings Preview

March 20, 2024 | businesswire.com

Simulations Plus Announces Second Quarter Fiscal Year 2024 Earnings and Conference Call Date

March 16, 2024 | finance.yahoo.com

SLP Apr 2024 40.000 put

March 14, 2024 | finance.yahoo.com

Investing in Simulations Plus (NASDAQ:SLP) five years ago would have delivered you a 110% gain

March 13, 2024 | businesswire.com

Simulations Plus to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum

March 6, 2024 | finance.yahoo.com

Director and 10% Owner Walter Woltosz Sells 20,000 Shares of Simulations Plus Inc (SLP)

February 15, 2024 | businesswire.com

Simulations Plus Extends Collaboration with Major Toxicology Research Agency

See More Headlines

Receive SLP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Simulations Plus and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 2/5 Dividend: 1/26/2024
Dividend Payable: 2/05/2024
Last Earnings: 4/03/2024
Today: 4/19/2024
Ex-Dividend for 5/6 Dividend: 4/26/2024
Dividend Payable: 5/06/2024
Next Earnings (Estimated): 7/04/2024
Fiscal Year End: 8/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Computer and Technology
Industry: Computer integrated systems design
Sub-Industry: N/A
Current Symbol: NASDAQ:SLP
CUSIP: N/A
CIK: 1023459
Web: www.simulations-plus.com
Phone: (661) 723-7723
Fax: 661-723-5524
Employees: 192
Year Founded: 1996

Price Target and Rating

Average Stock Price Target: $53.00
High Stock Price Target: $55.00
Low Stock Price Target: $51.00
Potential Upside/Downside: +19.3%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.53
Trailing P/E Ratio: 83.79
Forward P/E Ratio: 66.28
P/E Growth: N/A
Net Income: $9.96 million
Net Margins: 16.22%
Pretax Margin: 19.60%
Return on Equity: 7.95%
Return on Assets: 7.35%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 8.81
Quick Ratio: 8.81

Sales & Book Value

Annual Sales: $59.58 million
Price / Sales: 14.90
Cash Flow: $0.82 per share
Price / Cash Flow: 53.96
Book Value: $8.86 per share
Price / Book: 5.01

Miscellaneous

Outstanding Shares: 19,990,000
Free Float: 15,808,000
Market Cap: $887.76 million
Optionable: Optionable
Beta: 0.72

Social Links

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

Dr. Walter S. Woltosz M.A.S. (Age 79)
M.S., Co-Founder & Chairman
Comp: $80k
Mr. Shawn M. O'Connor (Age 64)
Chief Executive Officer
Comp: $847.56k
Mr. William Frederick (Age 60)
COO, CFO & Secretary
Comp: $443.12k
Mr. John Anthony DiBella M.S. (Age 44)
President of PBPK & Cheminformatics Solutions
Comp: $399.8k
Dr. Brett A. Howell Ph.D. (Age 40)
President of Quantitative Systems Pharmacology Solutions
Comp: $321.67k
Ms. Jill Fiedler-Kelly M.S. (Age 55)
President of Clinical Pharmacology & Pharmacometrics Services
Comp: $393.77k
Ms. Viera Lukacova Ph.D.
Chief Science Officer
Dr. Bud Nelson J.D.
Ph.D., VP of Corporate Counsel & Personal Data Protection Officer
Ms. Arlene Padron
Corporate Director of Marketing
Ms. Lindsay Luke
Executive Director of Human Resources

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

SLP Stock Analysis - Frequently Asked Questions

Should I buy or sell Simulations Plus stock right now?: 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Simulations Plus in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" SLP shares.
View SLP analyst ratings or view top-rated stocks.
What is Simulations Plus' stock price target for 2024?: 2 analysts have issued 12-month price objectives for Simulations Plus' stock. Their SLP share price targets range from $51.00 to $55.00. On average, they expect the company's stock price to reach $53.00 in the next year. This suggests a possible upside of 19.3% from the stock's current price.
View analysts price targets for SLP or view top-rated stocks among Wall Street analysts.
How have SLP shares performed in 2024?: Simulations Plus' stock was trading at $44.75 at the beginning of the year. Since then, SLP stock has decreased by 0.8% and is now trading at $44.41.
View the best growth stocks for 2024 here.
When is Simulations Plus' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, July 4th 2024.
View our SLP earnings forecast.
How were Simulations Plus' earnings last quarter?: Simulations Plus, Inc. (NASDAQ:SLP) released its earnings results on Wednesday, April, 3rd. The technology company reported $0.20 EPS for the quarter, topping the consensus estimate of $0.18 by $0.02. The technology company had revenue of $18.31 million for the quarter, compared to analyst estimates of $17.31 million. Simulations Plus had a trailing twelve-month return on equity of 7.95% and a net margin of 16.22%. Simulations Plus's revenue for the quarter was up 16.2% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.20 earnings per share.
How often does Simulations Plus pay dividends? What is the dividend yield for Simulations Plus?: Simulations Plus declared a quarterly dividend on Wednesday, April 3rd. Shareholders of record on Monday, April 29th will be given a dividend of $0.06 per share on Monday, May 6th. This represents a $0.24 dividend on an annualized basis and a dividend yield of 0.54%. The ex-dividend date of this dividend is Friday, April 26th.
Read our dividend analysis for SLP.

Is Simulations Plus a good dividend stock?: Simulations Plus (NASDAQ:SLP) pays an annual dividend of $0.24 per share and currently has a dividend yield of 0.54%. The dividend payout ratio is 45.28%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for SLP.
What ETFs hold Simulations Plus' stock?: ETFs with the largest weight of Simulations Plus (NASDAQ:SLP) stock in their portfolio include AdvisorShares Insiders Advantage ETF (SURE) and Franklin Genomic Advancements ETF (HELX).Syntax Stratified SmallCap ETF (SSLY).
What guidance has Simulations Plus issued on next quarter's earnings?: Simulations Plus updated its FY 2024 earnings guidance on Wednesday, April, 3rd. The company provided earnings per share guidance of 0.660-0.680 for the period, compared to the consensus earnings per share estimate of 0.660. The company issued revenue guidance of $66.0 million-$69.0 million, compared to the consensus revenue estimate of $67.2 million.
What other stocks do shareholders of Simulations Plus own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Simulations Plus investors own include Advanced Micro Devices (AMD), Cisco Systems (CSCO), Gilead Sciences (GILD), QUALCOMM (QCOM), NVIDIA (NVDA), Verizon Communications (VZ), CVS Health (CVS), Enterprise Products Partners (EPD), AbbVie (ABBV) and Pfizer (PFE).
Who are Simulations Plus' major shareholders?: Simulations Plus' stock is owned by a variety of retail and institutional investors. Top institutional investors include Wasatch Advisors LP (1.91%), Tributary Capital Management LLC (1.05%), Congress Asset Management Co. MA (0.86%), Hennion & Walsh Asset Management Inc. (0.18%), Chatham Capital Group Inc. (0.17%) and InTrack Investment Management Inc (0.16%). Insiders that own company stock include John Anthony Dibella II, John Kenneth Paglia, Lisa Lavange, Walter S Woltosz and Walter S Woltosz.
View institutional ownership trends.
How do I buy shares of Simulations Plus?: Shares of SLP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:SLP) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial